Relapsed Acute Myeloid Leukemia: Need for Innovative Treatment Strategies to Improve Outcome-Reference-Cited by-同舟云学术

Relapsed Acute Myeloid Leukemia: Need for Innovative Treatment Strategies to Improve Outcome

Published:2015-06 Issue: Volume:15 Page:S104-S108
ISSN:2152-2650
Container-title:Clinical Lymphoma Myeloma and Leukemia
language:en
Short-container-title:Clinical Lymphoma Myeloma and Leukemia

Author:

Badar Talha,Ravandi Farhad

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference57 articles.

1. Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B;Mayer;N Engl J Med,1994

2. Therapeutic advances in leukemia and myelodysplastic syndrome over the past 40 years;Kantarjian;Cancer,2008

3. Outcome of older patients with acute myeloid leukemia: an analysis of SEER data over 3 decades;Thein;Cancer,2013

4. Survival for older patients with acute myeloid leukemia: a population-based study;Oran;Haematologica,2012

5. Very poor survival of patients with AML who relapse after achieving a first complete remission: the Eastern Cooperative Oncology Group Experience;Rowe;ASH Annual Meeting Abstracts,2005

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Utility of Azacitidine in the Management of Acute Myeloid Leukemia: Update on Patient Selection and Reported Outcomes;Cancer Management and Research;2022-12

2. Protein kinase CK2 regulates AKT, NF-κB and STAT3 activation, stem cell viability and proliferation in acute myeloid leukemia;Leukemia;2016-08-01

3. Medical costs of treatment and survival of patients with acute myeloid leukemia in Belgium;Leukemia Research;2016-07

4. Prevalence and Prognostic Impact of Wilms' Tumor 1 (WT1) Gene, Including SNP rs16754 in Cytogenetically Normal Acute Myeloblastic Leukemia (CN-AML): An Iranian Experience;Clinical Lymphoma Myeloma and Leukemia;2016-03